licensing_iconLicensing

In addition to helping clients secure protection for their own intellectual property, BSKB represents companies looking to license intellectual property rights to others to expand markets for their goods and services or to obtain licenses from others for more freedom to sell a broader range of goods or services. BSKB also assists clients who look to cross-license intellectual property rights to create joint cooperation agreements with other companies or, as part of a more complex litigation scenario, to settle disputes with other companies.

BSKB provides legal opinions for both prospective licensors and licensees to ensure companies can move forward with licensing and acquisition plans with confidence in the value of the related intellectual property. BSKB also assists clients with an inventory and valuation of intellectual property rights and identifying and targeting potential licensing targets, as well as drafting simple to highly complex intellectual property licensing agreements.

 

Attorneys and Professionals

  • Richard Anderson

    D. Richard Anderson

    Partner

    View
  • Charles Gorenstein

    Charles Gorenstein

    Senior Counsel

    View
  • Hyuk Jung Kwon

    Hyuk Jung Kwon

    Associate

    View
  • Michael Mutter

    Michael K. Mutter

    Senior Counsel

    View
  • Jun Nakamara

    Jun (Atsushi) Nakamura

    Registered Patent Agent

    View
  • Whitney Remily

    Whitney Remily

    Of Counsel

    View

Related Articles

  • July 7, 2021

    When the Inventor is Artificial

    by MaryAnne Armstrong, Ph. D. | LSIPR

    MaryAnne Armstrong discusses whether the same tests for non-obviousness of biotech patents will be applied to pharma inventions developed using AI.

  • June 17, 2021

    Q&A with MaryAnne Armstrong: The future of AI in the life sciences

    by MaryAnne Armstrong, Ph. D. | LSIPR

    MaryAnne Armstrong, Ph. D., sits down with LSIPR to discuss artificial intelligence's impact on IP industry relating to life sciences and pharmaceuticals.

View All Articles

Recent News

  • September 23, 2021

    USPTO DOCX Filings

    Effective January 1, 2022, a USPTO surcharge fee of $400 (large entity), $200 (small entity) and $100 (micro entity) will apply for non-DOCX filings. The surcharge fee applies to utility non-provisional application filings (e.g., the specification, claims, and abstract must be in DOCX format to avoid the surcharge; drawings are not subject to this requirement). The DOCX surcharge does not apply to US National Stage Applications or PCT International Applications filed in the US Receiving Office. Drawings may be filed as PDF or DOCX documents. There is no surcharge for drawings not filed as DOCX documents. DOCX is a structured text-based Microsoft Word document. To avoid the USPTO surcharge, our policy at BSKB will be to require a DOCX format for all utility non-provisional applications (preferred for National Stage and PCT applications, but not required) filed on or after January 1, 2022. The USPTO already accepts DOCX filings, and we recommend that you commence sending applications in DOCX format as soon as possible.

  • May 28, 2021

    Len Svensson's meat substitute technology paper featured in IPWatchdog

    Leonard Svensson recently published an article in IPWatchdog, Inc. analyzing meat substitution companies and the patent protection being sought and obtained in the industry.

View All News

Contact Us